Prostate Cancer Imaging Agents – Is There a Difference?
December 10, 2024 | 12:00 pm ET
Organized as part of the SNMMI/ACNM "Hot Topics" Webinar Series

Organizer:
Katherine Zukotynski, BASc, MD, PhD, P.Eng; Gary Ulaner, MD, PhD, FACNM; Twyla Bartel, DO, MBA, FACNM

Moderator: Sanchay Jain, MBBS, MD

Speaker: Wolfgang Weber, MD

Course Summary:
 This presentation will give an overview of PSMA ligands in clinical use for PET/CT and PET/MR imaging of prostate cancer.

Course Objectives:

• Examine the three FDA approved PSMA ligands and their clinical indications.
• Discuss differences in the biodistribution between these ligands.
• Identify common pitfalls of the ligands.

CE Information:
CE Credit applications for physicians, pharmacists, physicists and technologists are pending. Check back for updates regarding CE Credit status.